BTIG analyst Mark Massaro downgraded Bionano Genomics (NASDAQ: BNGO) from Buy to Neutral.The analyst comments "We downgrade shares of BNGO ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE